BSE filing, NSE: SHAILY. Summary written from the filing by ALFA Finder's alert engine.
Shaily Engineering Plastics Ltd: key numbers
- Share price
- ₹3,072.00
- Market cap
- ₹14,117 Cr
- Revenue (annual)
- ₹990.7 Cr
- Net profit (annual)
- ₹169.9 Cr
- P/E (TTM)
- 79.8×Sector 52.2×
- Promoter holding
- 41.09%+0.00% QoQ
- FII holding
- 19.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shaily Engineering Plastics Ltd
All →Shaily Engineering Plastics Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 319.5 Cr (+24%), EBITDA Rs 101.8 Cr (31.9% margin), PAT Rs 61.3 Cr (+20%). Healthcare (+78%) drives growth; GLP-1 capacity and Abu Dhabi facility expansion underway.
Shaily Engineering Plastics Q2 FY27 Results: Net Profit ₹61.3 Cr, Up 19.7% YoY
Shaily Engineering Plastics Ltd reported revenue from operations of ₹319.5 Cr (+24.5% YoY) and net profit of ₹61.3 Cr (+19.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹61.3 Cr · +19.7% YoY
Shaily Engineering Plastics Board Meeting Date
Shaily Engineering Plastics will hold a board meeting on 29th October 2026 to consider unaudited standalone and consolidated financial results for the quarter ended September 2026.
Shaily Engineering Plastics Other Announcement
The company has filed its quarterly shareholding pattern under Regulation 31, disclosing promoter and public shareholding details as of the quarter ended September 30, 2026.
Shaily Engineering Plastics Annual General Meeting
Shaily Engineering Plastics Ltd shareholders approved an enabling resolution to raise up to ₹500 Crore. The decision was part of seven resolutions passed at the Annual General Meeting.
- Value
- ₹500.0 Cr
Shaily Engineering Plastics Fund Raise of ₹500 Cr
Shaily Engineering Plastics Ltd shareholders approved a fundraise of up to ₹500 Crore at their AGM. Other approved resolutions include dividend declaration and re-appointment of the Managing Director.
- Value
- ₹500.0 Cr
Other employee stock options announcements
All →Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.
Info Edge (India) Employee Stock Options
Info Edge's employee stock option trust sold 1,439 shares on 26 October 2026 under the ESOP scheme. The disposal reduces the trust's holding to 410,707 shares.
Motilal Oswal Financial Services Employee Stock Options
Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.
Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Coforge Employee Stock Options
Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.